Abstract
Rheumatic heart disease (RHD) significantly impacts patients' quality of life due to its long-term complications. RHD can lead to valvular damage, heart failure, arrhythmias, thromboembolic events, and endocarditis. According to statistical data, 15-18% of patients with rheumatism experience severe disease progression, resulting in congenital heart defects. These complications restrict patients' physical activity and create difficulties in performing daily tasks. As a result, their quality of life declines, negatively affecting their overall health and psychological well-being. Additionally, heart failure and arrhythmias associated with RHD can reduce life expectancy. Therefore, preventing RHD, ensuring early diagnosis, and implementing effective treatment strategies are crucial for improving patients' quality of life.